Sangamo Therapeutics Inc (NASDAQ: SGMO) is 32.35% higher on its value in year-to-date trading and has touched a low of $0.30 and a high of $3.18 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SGMO stock was last observed hovering at around $1.30 in the last trading session, with the day’s gains setting it 0.05%.
Currently trading at $1.35, the stock is -35.21% and -35.77% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 10.87 million and changing 3.85% at the moment leaves the stock 31.12% off its SMA200. SGMO registered 172.95% gain for a year compared to 6-month gain of 323.99%. The firm has a 50-day simple moving average (SMA 50) of $2.1056 and a 200-day simple moving average (SMA200) of $1.027.
The stock witnessed a -30.41% loss in the last 1 month and extending the period to 3 months gives it a 72.86%, and is -47.27% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 18.76% over the week and 14.36% over the month.
Sangamo Therapeutics Inc (SGMO) has around 405 employees, a market worth around $324.05M and $52.29M in sales. Profit margin for the company is -260.33%. Distance from 52-week low is 344.08% and -57.53% from its 52-week high. The company has generated returns on investments over the last 12 months (-203.60%).
The EPS is expected to grow by 68.32% this year.
Sangamo Therapeutics Inc (SGMO) Top Institutional Holders
127.0 institutions hold shares in Sangamo Therapeutics Inc (SGMO), with institutional investors hold 27.62% of the company’s shares. The shares outstanding are 208.62M, and float is at 199.18M with Short Float at 9.84%. Institutions hold 26.97% of the Float.
The top institutional shareholder in the company is WASATCH ADVISORS LP with over 20.09 million shares valued at $7.2 million. The investor’s holdings represent 11.1403% of the SGMO Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 14.06 million shares valued at $$5.04 million to account for 7.7963 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 11.9 million shares representing 6.5977% and valued at over $4.26 million, while BLACKROCK INC. holds 2.6078 of the shares totaling 4.7 million with a market value of $1.69 million.
Sangamo Therapeutics Inc (SGMO) Insider Activity
#####
